Sort
261,768 grants matching “gene therapy”
Hematopoietic Chimerism after Stem Cell Allografts
$892,086Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
$892,062Terry J Watnick · University Of Maryland Baltimore · U24 · FY2023 · DK
TNF-receptors and programmed cell death in regulation of autoimmunity
$892,002Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
National Coordinating Center (NCC) for the Polycystic Kidney Disease (PKD) Research and Translation Core Centers
$891,965Terry J Watnick · University Of Maryland Baltimore · U24 · FY2022 · DK
Combined cytokine therapy for sustained HIV remission
$891,856Vijayakumar Velu · Emory University · R01 · FY2020 · AI
Connectivity mapping identified novel combination therapy for glioblastoma
$891,835Nicole Shonka · University Of Nebraska Medical Center · R01 · FY2025 · CA
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$891,750Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2019 · ES
Clinical Analysis Of Disorders Of Hearing And Balance
$891,718Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC
Specifically and regulation TCR pathway protein tyrosine kinases and phosphatases
$891,703Arthur Weiss · University Of California, San Francisco · P01 · FY2012 · AI
Development of RespiraClear for targeted mucosal treatment of RSV infections
$891,585Richard A Cone · Mucommune, Llc · R44 · FY2022 · AI
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Therapeutic targets and novel anticancer agents for endocrine cancers
$891,488Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
COP Laboratory
$891,438Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$891,375Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Pharmacogenomics of Adrenal Suppression with Inhaled Corticosteroids (PhASIC)
$891,259Amber Dahlin · Brigham And Women'S Hospital · R01 · FY2023 · HL
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
$891,242Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Combined cytokine therapy for sustained HIV remission
$891,222Vijayakumar Velu · Emory University · R01 · FY2022 · AI
Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV
$891,217Nadia R Roan · J. David Gladstone Institutes · R01 · FY2025 · AI
Discovery of genetic interactions in cancer
$891,204Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Mesocale And Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)
$891,105John A Tainer · University Of Tx Md Anderson Can Ctr · R35 · FY2021 · CA
Regulation of y-secretase activity by modulatory proteins
$890,974Yueming Li · Sloan-Kettering Inst Can Research · R01 · FY2019 · AG
Mosaic: post-zygotic mutations in vascular malformations
$890,942James T Bennett · Seattle Children'S Hospital · R01 · FY2022 · HL
Visual Media Influences on Adolescent Smoking Behavior (Y10-14 Renewal)
$890,917James D. Sargent · Dartmouth College · R01 · FY2007 · CA
BASE TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS; TASK ORDER TITLE: EFGR AND KRAS VACCINE
$890,873Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA